Cargando…
The potential role of the three-dimensional-bioprinting model in screening and developing drugs
Recently, we have read with great interest the original article used different spatial configuration models of colorectal cancer (CRC) for validating the anti-tumor efficacy with Diiminoquinone. We feel obliged to provide new insight into the drug screening models by integrating and analyzing the or...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813933/ https://www.ncbi.nlm.nih.gov/pubmed/36620341 http://dx.doi.org/10.3748/wjg.v28.i47.6788 |
_version_ | 1784864024361435136 |
---|---|
author | Deng, Chao-Lin Wu, Bin |
author_facet | Deng, Chao-Lin Wu, Bin |
author_sort | Deng, Chao-Lin |
collection | PubMed |
description | Recently, we have read with great interest the original article used different spatial configuration models of colorectal cancer (CRC) for validating the anti-tumor efficacy with Diiminoquinone. We feel obliged to provide new insight into the drug screening models by integrating and analyzing the original method and result. These comments may provide comprehensive insights into three-dimensional drug screening models and the difference between pathologic subtypes in CRC. |
format | Online Article Text |
id | pubmed-9813933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-98139332023-01-06 The potential role of the three-dimensional-bioprinting model in screening and developing drugs Deng, Chao-Lin Wu, Bin World J Gastroenterol Letter to the Editor Recently, we have read with great interest the original article used different spatial configuration models of colorectal cancer (CRC) for validating the anti-tumor efficacy with Diiminoquinone. We feel obliged to provide new insight into the drug screening models by integrating and analyzing the original method and result. These comments may provide comprehensive insights into three-dimensional drug screening models and the difference between pathologic subtypes in CRC. Baishideng Publishing Group Inc 2022-12-21 2022-12-21 /pmc/articles/PMC9813933/ /pubmed/36620341 http://dx.doi.org/10.3748/wjg.v28.i47.6788 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Letter to the Editor Deng, Chao-Lin Wu, Bin The potential role of the three-dimensional-bioprinting model in screening and developing drugs |
title | The potential role of the three-dimensional-bioprinting model in screening and developing drugs |
title_full | The potential role of the three-dimensional-bioprinting model in screening and developing drugs |
title_fullStr | The potential role of the three-dimensional-bioprinting model in screening and developing drugs |
title_full_unstemmed | The potential role of the three-dimensional-bioprinting model in screening and developing drugs |
title_short | The potential role of the three-dimensional-bioprinting model in screening and developing drugs |
title_sort | potential role of the three-dimensional-bioprinting model in screening and developing drugs |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813933/ https://www.ncbi.nlm.nih.gov/pubmed/36620341 http://dx.doi.org/10.3748/wjg.v28.i47.6788 |
work_keys_str_mv | AT dengchaolin thepotentialroleofthethreedimensionalbioprintingmodelinscreeninganddevelopingdrugs AT wubin thepotentialroleofthethreedimensionalbioprintingmodelinscreeninganddevelopingdrugs AT dengchaolin potentialroleofthethreedimensionalbioprintingmodelinscreeninganddevelopingdrugs AT wubin potentialroleofthethreedimensionalbioprintingmodelinscreeninganddevelopingdrugs |